Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Todays House Positions
View:
Post by Riverfolk on Nov 01, 2021 4:53pm

Todays House Positions

House Positions for C:ARCH from 20211101 to 20211101
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 26,700 75,250 2.818 5,000 14,050 2.81 21,700 -61,200
7 TD Sec 22,730 64,626 2.843 1,050 2,952 2.811 21,680 -61,674
2 RBC 16,700 47,538 2.847 2,335 6,631 2.84 14,365 -40,907
9 BMO Nesbitt 7,200 20,407 2.834 0   7,200 -20,407
14 ITG 7,315 20,820 2.846 128 362 2.828 7,187 -20,458
13 Instinet 4,900 13,948 2.847 0   4,900 -13,948
84 Ind Trading 0   35 99 2.829 -35 99
80 National Bank 1,463 4,147 2.835 1,537 4,324 2.813 -74 177
68 Leede 50 140 2.80 133 375 2.82 -83 235
85 Scotia 705 2,002 2.84 1,450 4,138 2.854 -745 2,136
124 Questrade 300 843 2.81 2,150 6,060 2.819 -1,850 5,217
33 Canaccord 1,000 2,859 2.859 3,500 9,975 2.85 -2,500 7,116
79 CIBC 722 2,036 2.82 12,802 36,291 2.835 -12,080 34,255
1 Anonymous 25,935 73,128 2.82 85,600 242,487 2.833 -59,665 169,359
TOTAL 115,720 327,744 2.832 115,720 327,744 2.832 0 0
Comment by GoldenArm on Nov 02, 2021 8:36am
Thanks for the report. What it tells me is that this stock is not on the radar of any those that can move it. I'm sure they are watching and waiting but at some point they will jump in especially if they have inside track on the peer review and phase 3 plans. Phase 3 coming and we are still below $3!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities